Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Daito Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.39% and Operating profit at -14.40% over the last 5 years
2
The company has declared Negative results for the last 14 consecutive quarters
- INTEREST(Q) At JPY 33 MM has Grown at 10%
- CASH AND EQV(HY) Lowest at JPY 4,373 MM
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -41.67% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Daito Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Daito Pharmaceutical Co., Ltd.
-41.72%
0.12
57.10%
Japan Nikkei 225
66.43%
2.73
25.54%
Quality key factors
Factor
Value
Sales Growth (5y)
1.39%
EBIT Growth (5y)
-14.40%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.37
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.79
Tax Ratio
40.30%
Dividend Payout Ratio
55.80%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.93%
ROE (avg)
7.40%
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.86
EV to EBIT
18.48
EV to EBITDA
7.19
EV to Capital Employed
0.88
EV to Sales
1.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.75%
ROE (Latest)
4.39%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
7What is working for the Company
DIVIDEND PER SHARE(HY)
Highest at JPY 2.75
RAW MATERIAL COST(Y)
Fallen by -1.84% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.16 times
DEBTORS TURNOVER RATIO(HY)
Highest at 2.75 times
PRE-TAX PROFIT(Q)
At JPY 778 MM has Grown at 60.41%
NET PROFIT(Q)
At JPY 534.61 MM has Grown at 84.34%
-11What is not working for the Company
INTEREST(Q)
At JPY 33 MM has Grown at 10%
CASH AND EQV(HY)
Lowest at JPY 4,373 MM
Here's what is working for Daito Pharmaceutical Co., Ltd.
Dividend per share
Highest at JPY 2.75 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (JPY)
Pre-Tax Profit
At JPY 778 MM has Grown at 60.41%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 534.61 MM has Grown at 84.34%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Inventory Turnover Ratio
Highest at 2.16 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 2.75 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -1.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Daito Pharmaceutical Co., Ltd.
Interest
At JPY 33 MM has Grown at 10%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Cash and Eqv
Lowest at JPY 4,373 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






